Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pelletier

Showing results (321-330 of 329) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 329 results.
Cancer Research Communications|March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N TrialsBenjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Journal of Occupational and Environmental Medicine|August 26, 2014
Do workplace health promotion (wellness) programs work?Ron Z Goetzel, Rachel Mosher Henke, Maryam Tabrizi, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 26, 2007
A faculty development program to train tutors to be discussion leaders rather than facilitatorsHelen M Shields, Daniel Guss, Samuel C Somers, et al.
Cancer Immunology Research|April 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune ResponsesRohan Diwanji, Neil A O'Brien, Jiyoung E Choi, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory leadH Du, T Matsushima, M Spyvee, et al.
Trials|December 12, 2023
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trialEdward L Snyder, Michael E Sekela, Ian J Welsby, et al.
Journal of the American College of Cardiology|July 5, 2005
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine)John H K Vogel, Steven F Bolling, Rebecca B Costello, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Cancer Immunology Research|July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the TumorPaul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Pageof 33

Showing results (321-330 of 329) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 329 results.
Cancer Research Communications|March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N TrialsBenjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Journal of Occupational and Environmental Medicine|August 26, 2014
Do workplace health promotion (wellness) programs work?Ron Z Goetzel, Rachel Mosher Henke, Maryam Tabrizi, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 26, 2007
A faculty development program to train tutors to be discussion leaders rather than facilitatorsHelen M Shields, Daniel Guss, Samuel C Somers, et al.
Cancer Immunology Research|April 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune ResponsesRohan Diwanji, Neil A O'Brien, Jiyoung E Choi, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory leadH Du, T Matsushima, M Spyvee, et al.
Trials|December 12, 2023
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trialEdward L Snyder, Michael E Sekela, Ian J Welsby, et al.
Journal of the American College of Cardiology|July 5, 2005
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine)John H K Vogel, Steven F Bolling, Rebecca B Costello, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Cancer Immunology Research|July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the TumorPaul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Pageof 33